Amedisys second quarter net service income decreases 11.5 percent to $373 levitra vs viagra .7 million Amedisys, Inc.7 million in comparison to $422.3 million in 2010 2010, a decrease of $48.6 million or 11.5 percent. Same store agencies reduced $45.4 million, $15.6 million of the decrease related to companies closed or consolidated during 2010 offset by $12.4 million in revenue related to start-up and acquisition agencies. Of $21.7 million in comparison to $32.2 million this year 2010, a decrease of $10.5 or 32.7 percent.75 compared to $1.13 per diluted share this year 2010, a decrease of 33.6 percent. The weighted average number of diluted shares exceptional increased to around 29.7 million compared to $63.4 million this year 2010, a loss of 24.7 percent.6 million and adding back $1.2 million or $0.08 and $0.
Among the brand new awards are two prestigious American Cancer tumor Society Analysis Professorship Awards: Dr. Mary L. Disis, MD, at University of Washington, is studying the concept of using vaccines that target cancer initiation to prevent colon cancer. Her group has identified proteins that are overexpressed at the initial stages of disease, and so are found in polyps even. Her group will determine whether those genes are essential for colon cancer survival, and if they are, develop a vaccine to stimulate the body's immune system hoping of preventing the disease. This mouse study will lay the foundation for human studies later on. Nancy Krieger, PhD, at Harvard University College of Public Health will work to problem the mainstream approach to social inequalities in cancers, with the goal of establishing a audio scientific basis for the elimination of the inequalities.